网络药理学,分子对接和体外实验验证,以揭示Areca Catechu的抗糖尿病机制

Sanket Jadhav1, RajaSekhar Reddy Alavala2, Ashish Kanhed3

  • 1Pharmaceutical Quality Assurance, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies, Mumbai, 400056 India.

In silico pharmacology
|November 10, 2025
PubMed
概括

阿雷卡甲坚果化合物通过抑制二氧化碳无水酶II (CA-II) 显示出抗糖尿病潜力. 酸显示出显著的CA-II抑制活性,这表明糖尿病管理的新治疗机制.